INTERNATIONAL PATENT: TRANSCRIPTA BIO, INC. FILES APPLICATION FOR "OMAVELOXOLONE FOR TREATING OR PREVENTING MITOCHONDRIAL DYSFUNCTION CAUSED BY SURF1 LEIGH SYNDROME"

GENEVA, Feb. 18 -- TRANSCRIPTA BIO, INC. (1804 Embarcadero RdSuite 201Palo Alto, California 94303) filed a patent application (PCT/US2024/040858) for "OMAVELOXOLONE FOR TREATING OR PREVENTING MITOCHONDRIAL DYSFUNCTION CAUSED BY SURF1 LEIGH SYNDROME" on Aug 02, 2024. With publication no. WO/2025/034608, the details related to the patent application was published on Feb 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KARKOUTI, Omid (c/o Transcripta Bio, Inc.1804 Embarcadero Rd, Suite 201Palo Alto, California 94303), BELLUCCI, Joseph (c/o Transcripta Bio, Inc.1804 Embarcadero Rd, Suite 201P...